Ladenburg Thalmann resumed coverage on Cellectar Biosciences with a new price target

12/5/24 8:32:15 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Ladenburg Thalmann resumed coverage of Cellectar Biosciences with a rating of Buy and set a new price target of $13.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CLRB

Date	Price Target	Rating	Analyst
12/5/2024	$13.00	Buy	Ladenburg Thalmann